Platelet α- and γ-synucleins in Parkinson's disease and normal control subjects

Journal of Alzheimer's Disease

Volumn 4, Issue 4, 2002, Pages 309-315

  Li, Qiao Xin ^a   Campbell, Bruce C V ^a   McLean, Catriona A ^a   Thyagarajan, Domimic ^a   Gai, Wei Ping ^a   Kapsa, Robert M ^a   Beyreuther, Konrad ^a   Masters, Colin L ^a   Culvenor, Janetta G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Parkinson's disease; Platelet; synuclein; synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; THROMBIN;

AGE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL; THROMBOCYTE; WESTERN BLOTTING;

EID: 0036669811     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4406     Document Type: Article

References (21)

1. M.H. Polymeropoulos, Genetics of Parkinson's disease, Ann. NY Acad. Sci. 920 (2000), 28-32.
2. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, P.E. Castillo, N. Shinsky, J.M. Verdugo, M. Armanini, A. Ryan, M. Hynes, H. Phillips, D. Sulzer and A. Rosenthal, Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron 25 (2000), 239-252.
3. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk and L. Mucke, Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders, Science 287 (2000), 1265-1269.
4. C.F. Lippa, H. Fujiwara, D.M. Mann, B. Giasson, M. Baba, M.L. Schmidt, L.E. Nee, B. O'Connell, D.A. Pollen, P. St George-Hyslop, B. Ghetti, D. Nochlin, T.D. Bird, N.J. Cairns, V.M. Lee, T. Iwatsubo and J.Q. Trojanowski, Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes, Am. J. Pathol. 153 (1998), 1365-1370.
5. J.G. Culvenor, C.A. McLean, S. Cutt, B.C. Campbell, F. Maher, P. Jakala, T. Hartmann, K. Beyreuther, C.L. Masters and Q.-X. Li, Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited. NAC and α-synuclein are not associated with Aβ amyloid, Am. J. Pathol. 155 (1999), 1173-1181.
6. C. Lavedan, The synuclein family, Genome Res. 8 (1998), 871-880.
7. J.E. Galvin, K. Uryu, V.M. Lee and J.Q. Trojanowski, Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein, Proc. Natl. Acad. Sci. USA 96 (1999), 13450-13455.
8. B.C. Campbell, Q.-X. Li, J.G. Culvenor, P. J?k?l?, R. Cappai, K. Beyreuther, C.L. Masters and C.A. McLean, Accumulation of insoluble α-synuclein in dementia with Lewy bodies, Neurobiol. Dis. 7 (2000), 192-200.
9. Q.-X. Li, S.J. Fuller, K. Beyreuther and C.L. Masters, The amyloid precursor protein of Alzheimer disease in human brain and blood, J. Leukoc. Biol. 66 (1999), 567-574.
10. Q.-X. Li, G. Evin, D.H. Small, G. Multhaup, K. Beyreuther and C.L. Masters, Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets, J. Biol. Chem. 270 (1995), 14140-14147.
11. K. Uéda, T. Saitoh and H. Mori, Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid, Biochem. Biophys. Res. Commun. 205 (1994), 1366-1372.
12. M. Hashimoto, M. Yoshimoto, A. Sisk, L.J. Hsu, M. Sundsmo, A. Kittel, T. Saitoh, A. Miller and E. Masliah, NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation, Biochem. Biophys. Res. Commun. 237 (1997), 611-616.
13. W.E. Van Nostrand, A.H. Schmaier, J.S. Farrow and D.D. Cunningham, Protease nexin-II (amyloid beta-protein precursor): A platelet alpha-granule protein, Science 248 (1990), 745-748.
14. A.J. Hughes, Y. Ben-Shlomo, S.E. Daniel and A.J. Lees, What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study, Neurology 42 (1992), 1142-1146.
15. B.C. Campbell, C.A. McLean, J.G. Culvenor, W.P. Gai, P.C. Blumbergs, P. Jäkälä, K. Beyreuther, C.L. Masters and Q.-X. Li, The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease, J. Neurochem. 76 (2001), 87-96.
16. A. Iwai, M. Yoshimoto, E. Masliah and T. Saitoh, Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic, Biochemistry 34 (1995), 10139-10145.
17. C. Ferrarese, C. N. Pecora, R. Piolti, M. Frigo, G. Bianchi, G. Sala, B. Begni, R. Riva and L. Frattola, Reduced platelet glutamate uptake in Parkinson's disease, J. Neural. Transm. 106 (1999), 685-692.
18. D.F. Clayton and J.M. George, Synucleins in synaptic plasticity and neurodegenerative disorders, J. Neurosci. Res. 58 (1999), 120-129.
19. E.C. Shin, S.E. Cho, D.K. Lee, M.W. Hur, S.R. Paik, J.H. Park and J. Kim, Expession patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages, Mol. Cells 10 (2000), 65-70.
20. R. Borghi, R. Marchese, A. Negro, L. Marinelli, G. Forloni, D. Zaccheo, G. Abbruzzese and M. Tabaton, Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects, Neurosci. Lett. 287 (2000), 65-67.
21. A.H. Schapira, M. Gu, J.W. Taanman, S.J. Tabrizi, T. Seaton, M. Cleeter and J.M. Cooper, Mitochondria in the etiology and pathogenesis of Parkinson's disease, Ann. Neurol. 44(3) (Suppl 1) (1998), S89-98.